606 related articles for article (PubMed ID: 16459344)
1. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Playford EG; Webster AC; Sorrell TC; Craig JC
J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
[TBL] [Abstract][Full Text] [Related]
2. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (4):CD000026. PubMed ID: 11034669
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
4. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.
Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334
[TBL] [Abstract][Full Text] [Related]
5. Antifungal prophylaxis in immunocompromised hosts.
Reents S; Goodwin SD; Singh V
Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
[TBL] [Abstract][Full Text] [Related]
6. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (2):CD002033. PubMed ID: 10796846
[TBL] [Abstract][Full Text] [Related]
7. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Gotzsche PC; Johansen HK
Cochrane Database Syst Rev; 2000; (2):CD000026. PubMed ID: 10796687
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
Johansen HK; Gotzsche PC
Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
Winston DJ; Pakrasi A; Busuttil RW
Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
[TBL] [Abstract][Full Text] [Related]
10. Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials.
Dupont H; Mahjoub Y; Chouaki T; Lorne E; Zogheib E
Crit Care Med; 2017 Nov; 45(11):1937-1945. PubMed ID: 28857851
[TBL] [Abstract][Full Text] [Related]
11. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
12. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.
Pelz RK; Hendrix CW; Swoboda SM; Diener-West M; Merz WG; Hammond J; Lipsett PA
Ann Surg; 2001 Apr; 233(4):542-8. PubMed ID: 11303137
[TBL] [Abstract][Full Text] [Related]
13. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
14. Antifungal prophylaxis in bone marrow transplant.
Lam HH; Althaus BL
Ann Pharmacother; 1995 Sep; 29(9):921-4. PubMed ID: 8547742
[TBL] [Abstract][Full Text] [Related]
15. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
Winston DJ; Chandrasekar PH; Lazarus HM; Goodman JL; Silber JL; Horowitz H; Shadduck RK; Rosenfeld CS; Ho WG; Islam MZ; Buell DN
Ann Intern Med; 1993 Apr; 118(7):495-503. PubMed ID: 8442620
[TBL] [Abstract][Full Text] [Related]
18. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
